Rock Weekly – NEW

  • Expert analysis and proprietary data (e.g., longitudinal funding data, consumer adoption) 100% 100%
  • Insightful takes from the Rock Health Advisory team 100% 100%
  • Spotlight on startups, deals, partnerships, and emerging trends 100% 100%

    Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

    Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

    Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

    Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

    Name Goes Here

    U

    Apple makes an acquisition

    Big names making moves in healthcare want to keep you healthy—at home. Apple, on its quest for new health features, scooped up pediatric asthma monitoring co Tueo Health. Comcast, hoping to prevent readmissions, aims to pilot its in-home monitoring device by year end.
    Read More

    What the FDA wants you to know about Pre-Cert

    It's been a busy month for digital health over at the FDA. In addition to a warning for patients hacking insulin pumps, the agency issued a handful of clearances—from AliveCor’s six-lead smartphone ECG to two AI tools to make radiologists' jobs easier.
    Read More

    When an app store isn’t enough

    Consumer genomics startups are finding that it’s tough to build a large-scale consumer business on top of gene sequencers. One explanation? The information just isn’t that useful for most people. In response, companies are shifting their focus to partner with providers who can turn DNA test results into action. (One researcher’s journey makes the case for such an approach—and raises concerns of overtreatment.)
    Read More

    Shots fired: AliveCor calls out Apple

    Read More

    What 4K Americans think about digital health

    Read More